PHYX Physiometrix (MM)

Physiometrix, Inc. Discloses Filing of Form 10-K NO. BILLERICA, Mass., April 1 /PRNewswire-FirstCall/ -- Physiometrix, Inc. (NASDAQ:PHYX) announced today that its 2004 financial statements included in the company's Form 10-K, filed on March 31, 2005 with the Securities and Exchange Commission, contained a going concern qualification from its auditors. This announcement is made to comply with NASDAQ rule 4350(b) requiring disclosure of such audit opinion. The uncertainty described in the Form 10-K was based upon the company's cash balance as of December 31,2004, which was not sufficient to fund projected operations over the next year and does not take into account any potential future cash inflows. For discussion of the company's plans regarding this situation, please refer to the Form 10-K dated March 31, 2005. Physiometrix Inc. designs, manufactures and markets noninvasive medical products -- based on novel gel materials, sophisticated signal-processing electronics technologies, and proprietary software -- for use in anesthesia- monitoring during surgical procedures. For more information, please visit the Company's Web site at http://www.physiometrix.com/. Statements in this press release regarding Physiometrix's growth and future business results of the Company are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual results to differ materially from any forward-looking statements made by the Company include, among others, revenue estimates, dependence on existing and future products, dependence upon third-party distribution and sales arrangements, the existence of alternative technologies and the potential emergence of new methods for consciousness monitoring, uncertainty of market acceptance, intense competition, partnership agreements, and government regulations, especially regulatory approvals. These and other relevant risks are described in the Company's Form 10-K dated March 31, 2005 filed with the SEC. The Company disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release. CONTACT: Daniel W. Muehl, CFO Physiometrix Inc. 978-670-2422 DATASOURCE: Physiometrix, Inc. CONTACT: Daniel W. Muehl, CFO of Physiometrix Inc., +1-978-670-2422 Web site: http://physiometrix.com/

Copyright